aMoon Fund is a global HealthTech and Life Sciences investment firm based in Israel. It specializes in investing in early and late-stage companies that leverage groundbreaking science and technology to transform healthcare. Services include investment through aMoon Velocity and aMoon Growth, as well as support through aMoon Alpha, which enhances execution capabilities and unlocks value creation opportunities. The target audience is passionate entrepreneurs in the healthcare sector. Unique Selling Proposition (USP): aMoon's focus on trust, team diversity, and a commitment to accelerating healthcare transformation through disruptive technologies sets it apart.